Hardman Johnston Global Advisors LLC Abbott Laboratories Transaction History
Hardman Johnston Global Advisors LLC
- $1.98 Billion
- Q3 2025
A detailed history of Hardman Johnston Global Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 37,584 shares of ABT stock, worth $4.89 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
37,584
Previous 45,044
16.56%
Holding current value
$4.89 Million
Previous $6.13 Million
17.83%
% of portfolio
0.25%
Previous 0.29%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,651Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...